Medication info
Clopidogrel 75 mg Tablet (Clopidogrel Bisulfate)

Clopidogrel 75 mg Tablet (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200703654 · Approved 2007.03.29 · Insurance code 642102390

Summary

Main use
Improvement of acute coronary syndrome and symptoms of atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of clopidogrel 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly once daily. 3. In patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of acute coronary syndrome and symptoms of atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also helps reduce the risk of mortality, myocardial infarction, stroke, or refractory ischemia associated with cardiovascular abnormalities in adult patients with acute coronary syndrome, particularly those with unstable angina or non-ST elevation myocardial infarction. Additionally, in patients with atrial fibrillation who have multiple vascular risk factors and cannot use vitamin K antagonists and have a low risk of bleeding, it is effective in reducing the risk of stroke and other thrombosis. This drug plays a crucial role in protecting cardiovascular health and reducing risk, thereby improving patients' conditions.

How to take

Adult dose

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of clopidogrel 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly once daily. 3. In patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication is a drug that inhibits platelet aggregation to prevent the formation of blood clots. The effectiveness of this medication may be reduced in patients who do not produce sufficient active metabolites due to certain genetic factors, and in such cases, alternative treatment should be considered. Additionally, concomitant use of medications that activate CYP2C19 enzymes may increase drug concentration and the risk of bleeding, so co-administration should be avoided. This drug should not be used in patients with allergies to this medication, those with severe bleeding, severe liver damage, nursing women, and patients with genetic issues such as lactose intolerance. Caution should be exercised in patients with a high risk of bleeding, liver or kidney dysfunction, acute stroke, hypertension, elderly individuals, and underweight patients, and the medication should be discontinued in advance if surgery is planned. Since this drug may increase the risk of bleeding, notify healthcare professionals immediately if bleeding symptoms occur and get a blood test. Additionally, be careful as there may be an increased risk of bleeding when this medication is used together with other antiplatelet agents, anticoagulants, non-steroidal anti-inflammatory drugs, and selective serotonin reuptake inhibitors (SSRIs). During pregnancy, while the risk to the fetus is low, there may be an increased risk of bleeding during delivery, so discontinuation of the drug before delivery may be necessary. If breastfeeding, it is advisable to stop breastfeeding or discontinue the medication due to the possibility of the drug being secreted in breast milk. The safety and efficacy of this drug in children have not been established, and in elderly patients, the risk of side effects such as bleeding may be higher due to reduced physical function, thus requiring dosage adjustment and monitoring. In cases of overdose, bleeding time may be prolonged and bleeding complications may occur, so immediate medical attention is required for appropriate treatment. This drug should be stored out of reach of children and it is advisable not to transfer it to other containers.

Side effects

bleeding, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, hemorrhagic stroke, thrombocytopenia, neutropenia, aplastic anemia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, urinary tract infection, headache, dizziness, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, purpura, blood in stool, thrombocytopenia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, allergy symptoms, ischemic necrosis, thrombocytopenia, prolonged bleeding time, aplastic anemia, hypochromic anemia, agranulocytosis, granulocytopenia, leukemia, leukopenia, neutropenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythema multiforme, maculopapular rash, urticaria, abnormal kidney function, acute kidney failure, Kounis syndrome, anaphylactoid reaction, serum sickness, confusion, hallucination, taste disorder, taste loss, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, maculopapular rash, urticaria, itching, angioedema, vesicular skin dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, maintaining a storage temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.